Jan 8, 2025 · Medicare drug plans can now cover Eli Lilly 's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to Zepbound,...

Jan 10, 2025 · Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and Drug Administration (FDA) approval last month.

Jan 12, 2025 · CMS announced that Medicare drug plans (Part D or Medicare Advantage) could now cover Zepbound (tirzepatide) when doctors prescribe it to patients for obesity and sleep apnea. This is not the opening of floodgates. It is movement from an absolute “no” to “maybe.”

Jan 9, 2025 · The Centers for Medicare and Medicaid Services on Wednesday confirmed that certain Medicare plans can now cover the use of Eli Lilly ’s blockbuster obesity drug Zepbound (tirzepatide) for use in obstructive sleep apnea, according to CNBC.

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment.

6 days ago · To determine if Zepbound is covered under Medicare, it’s essential to understand the eligibility criteria. Generally, Medicare covers medications that are deemed medically necessary. Here are some key points to consider: You must be 65 years or …

Jan 8, 2025 · Zepbound, a ⁢drug that has seen⁤ skyrocketing demand despite its steep $1,000 monthly price tag, is now eligible for Medicare Part D coverage—but with a catch. The ‌drug can only ⁢be covered if it’s prescribed for obstructive sleep apnea (OSA), a …

Jan 8, 2025 · Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for Medicare & Medicaid Services said on Wednesday. Zepbound in December became the first drug approved in the U.S. for sleep apnea, but commercial insurers and...

Jan 9, 2025 · Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound (tirzepatide) can now be covered by Medicare insurance plans for use in sleep apnea, broadening access to the weight-loss treatment.